Tolemy Bio is a Cambridge and Barcelona-based biotech startup building the virtual-cell intelligence layer for modern biopharma. Founded in 2024 by Alex Ward and Caelan Anderson, the company’s platform, Orbit, combines experimental data, agentic AI and virtual-cell models to help advanced therapy and biologics teams make their cell biology more predictable, interpretable and controllable.
Tolemy Bio
- Life Sciences
- Cambridge, United Kingdom
- £1.2m
- tolemy.bio
- Update Information
More venture news
- 7 Jul 2026
Healome TherapeuticsHealome Therapeutics raises £2m to advance eye-drop matrix technology treating dry eye and ocular surface disease
SeedLife Sciences - 6 Jul 2026
Revolver TherapeuticsRevolver Therapeutics raises £600k in funding led by QantX to develop peptides that shut down cancer-driving proteins
EquityLife Sciences - 25 Jun 2026
RQ BioRQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza
Series ALife Sciences
